CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-134646 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Clinical Trial Materials and Supplies Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET

7.1 GLOBAL CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA CLINICAL TRIAL MATERIALS AND SUPPLIES MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Thermo-Fisher Scientific Inc.(U.S.)

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Capsugel Inc. (U.S.)

16.3 Eurofins Scientific Inc. (Luxembourg)

16.4 Intertek Group Plc (U.K.)

16.5 Catalent Inc.(U.S.)

16.6 Bilcare Inc. (U.S.)

16.7 Avomeen Analytical Services Inc. (U.S.)

16.8 Recipharma A.B. (Sweden)

16.9 Biocair International Ltd. (U.K.)

16.10 Mayne Pharma Group Ltd. (Australia)

16.11 Almac Group Ltd.

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Services
Logistics and Distribution
Manufacturing and Packaging
 o IMPs and INDs
 o Placebos
 o Assays and Testkits
 o Others
Documentation
Quantitative Clinical Development
Clinical Operations

By Clinical Trial Type
Therapeutic and Prevention
 o Vaccines
 o Drug Discovery and Development
 o Therapeutic Devices
 o Biosimilars
 o Therapeutic Assays
 o Therapeutic Procedures
Diagnostics
 o Diagnostic Assay
 o Diagnostic Devices

By Phase
Phase 3
Phase 2
Phase 1

By Medical Specialty
Oncology
CNS and Mental Disorders
Diabetes
Cardiovascular Diseases
Dermatology
Respiratory Diseases
Blood Disorders
Gastrointestinal Diseases
Infectious Diseases
Ophthalmology
Rare Diseases

By End User
Pharmaceuticals and Biologics
Contract Research Organization
Medical Device Companies

Companies

Thermo-Fisher Scientific Inc.(U.S.)
Capsugel Inc. (U.S.)
Eurofins Scientific Inc. (Luxembourg)
Intertek Group Plc (U.K.)
Catalent Inc.(U.S.)
Bilcare Inc. (U.S.)
Avomeen Analytical Services Inc. (U.S.)
Recipharma A.B. (Sweden)
Biocair International Ltd. (U.K.)
Mayne Pharma Group Ltd. (Australia)
Almac Group Ltd.

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.